Home › Oral Cancer › Minnesota › Saint Paul
Oral Cancer clinical trials in Saint Paul, MN
3 studies for Oral Cancer are looking for participants at sites in and around Saint Paul (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Saint John's Hospital - Healtheast, Maplewood · 5 mi away
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Saint John's Hospital - Healtheast, Maplewood · 5 mi away
- and 1 more
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 3 more
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- St. Louis, MO8 studies
- New York City, NY8 studies
- Chicago, IL8 studies
- Durham, NC7 studies
- Houston, TX7 studies
- Milwaukee, WI7 studies
- Portland, OR7 studies
- Ann Arbor, MI7 studies
- Pittsburgh, PA7 studies
- Kansas City, MO7 studies
- Richmond, VA7 studies
Other studies in Saint Paul
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer13 studies
- Lung Cancer13 studies
- Breast Cancer12 studies
- Colorectal Cancer9 studies
- Ovarian Cancer8 studies
- Metastatic Cancer7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Endometrial Cancer6 studies
- Bladder Cancer6 studies
- Melanoma6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.